47.95
Akero Therapeutics Inc (AKRO) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Research and Development |
0.45%
69.25
|
69.57 | 69.29 | 72.23 | 55.32 |
Interest Income/Expense |
1.56%
1.172
|
1.154 | 1.20 | 1.246 | 1.231 |
Operating Income/Loss |
0.01%
-80.87
|
-80.88 | -78.03 | -81.70 | -65.74 |
Income/Loss From Continuing Operations Before Tax |
0.31%
-70.50
|
-70.72 | -70.02 | -72.70 | -55.99 |
Income/Loss From Continuing Operations After Tax |
0.31%
-70.50
|
-70.72 | -70.02 | -72.70 | -55.99 |
|
0.31%
-70.50
|
-70.72 | -70.02 | -72.70 | -55.99 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3.90%
81.72
|
78.66 | 1.154 | 69.44 | 69.16 |
Diluted Average Shares |
3.90%
81.72
|
78.66 | 1.154 | 69.44 | 69.16 |
Basic Earnings Per Share |
4.44%
-0.86
|
-0.90 | -0.99 | -1.05 | -0.81 |
Diluted Earnings Per Share |
4.44%
-0.86
|
-0.90 | -0.99 | -1.05 | -0.81 |
Common Stock Dividends |
-
|
- | - | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):